Home/Issues/Issue 03/Study

In vitro and mouse models Publication date verified at source

Two common emulsifiers disrupted the gut barrier in lab and mouse models

AI narration, generated on first listen
Journal
Allergy
Authors
Yazici D, Hayashi Y, Pat Y, Nadeau K, Palomares O, Morita H, Akdis CA, et al.
Published
8 August 2026
Source
PMID 42568319 · DOI 10.1111/all.70473
Design
Experimental toxicology across three model systems: gut on a chip, human stem cell derived colon organoids, and mice, testing soy lecithin and DATEM at doses described as daily exposure levels, with barrier integrity (transepithelial electrical resistance, zona occludens-1), cytotoxicity, inflammatory signalling and IgE readouts.
Sample
No human participants. Chip and organoid models plus mice; numbers per model were not given in the digest note.

Two emulsifiers common in processed food, soy lecithin and diacetyl tartaric acid esters of mono- and diglycerides (DATEM), were tested in gut on a chip models, human stem cell derived colon organoids and mice.

Both produced dose dependent cytotoxicity and barrier disruption at daily exposure doses, measured as reduced transepithelial electrical resistance and disorganized zona occludens-1, and activated TNF, NF-kappaB, the unfolded protein response and apoptosis.

Soy lecithin also induced oxidative stress and raised IgE in fed mice; DATEM enhanced IL-4 induced IgE in human peripheral blood mononuclear cells. The authors say directly that this challenges the presumed safety of both ingredients.

The numbers

Emulsifiers testedsoy lecithin and DATEM
Barrier effectdose dependent cytotoxicity and barrier disruption at daily exposure doses; reduced transepithelial electrical resistance, disorganized zona occludens-1
Pathways activatedTNF, NF-kappaB, unfolded protein response, apoptosis
IgE findingssoy lecithin raised IgE in fed mice; DATEM enhanced IL-4 induced IgE in human PBMCs

What this does not show

  • Anything in humans. Gut on a chip models, organoids and mice. In vitro plus murine emulsifier work has a track record of not replicating in people.
  • That everyday intake causes allergy or gut disease. IgE rises in fed mice and IL-4 stimulated human cells are mechanistic signals, not clinical outcomes in eaters of these ingredients.
  • A settled interpretation. The findings sit inside the epithelial barrier hypothesis associated with the Akdis group, which has been contested since 2021 and should be expected to be contested here.
  • Real world dose equivalence. Doses were described as daily exposure levels, but translating chip, organoid and mouse dosing to human dietary exposure is itself model dependent.

Caveats worth holding

  • Not a human study. In vitro and murine emulsifier findings have repeatedly failed to replicate in people, so this is a mechanism flag rather than a dietary conclusion.
  • Retrieved after the digest was first written, via the PubMed connector, and summarised from the record rather than full text.
  • The epithelial barrier hypothesis framing behind this work has been contested since 2021.
  • Effect magnitudes and per model sample sizes were not captured in the digest note.

Newsletter

Each issue by email, when the newsletter launches. Leaving your address puts you on the list, nothing is sent yet.